Είστε εδώ
Διεθνή Νέα
New EMA recommendations for the use of CORLENTOR/PROCORALAN
(21/11/2014)
Servier launches Cardiological, a mobile medical application to understand cardiovascular diseases
(03/7/2014)
Servier Research Group announces the death of President-Founder Dr. Jacques Servier
(16/4/2014)
(21/2/2014)
Curie-Cancer and Servier continue a renewed partnership in cancer research
(30/1/2014)
PROTELOS / OSSEOR: European Committee for Pharmacovigilance Recommendation
(10/1/2014)
Servier's takeover bid of Egis proves successful
(08/11/2013)
(19/09/2013)
Servier concludes a license agreement with SIMM for the development in China of lucitanib
(13/09/2013)
SERVIER CANADA announces the creation of a new Centre of Excellence in Clinical Research
(09/09/2013)
ISHR – Servier Research Fellowship
(06/08/2013)
The 2013 Servier Award in Microcirculation(06/08/2013)
(30/07/2013)
Galapagos delivers novel osteoarthritis molecules in alliance with Servier
(25/07/2013)
Servier Research Grant in Hypertension
(16/07/2013)
Pierre Delmas Prize 2013 winner
(16/07/2013)
Amgen and Servier announce product collaboration
(09/07/2013)
XOMA Transfers Perindopril Franchise Rights to Symplmed
(03/07/2013)
XOMA's Development Partner SERVIER Launches Proof-of-Concept Clinical Program for Gevokizumab
(25/06/2013)
miRagen Therapeutics Achieves First Milestone in Strategic Alliance with Servier
(23/05/2013)
(30/04/2013)
Vernalis and Servier Extend Oncology Collaboration
(06/03/2013)
Achievement of new milestones in Galapagos alliances with Servier
(06/03/2013)
(20/02/2013)
The UIP/Servier Research Fellowship 2013/2015 - Call for application
(04/01/2013)
Valdoxan® (agomelatine): Award of the Italian Prix Galien 2012
(03/12/2012)
(29/11/2012)
Professor Caroline Dive, University of Manchester, winner of the 2012 Pasteur-Weizmann/Servier Prize
(28/11/2012)
Servier Research Grant in Hypertension: call for application
(28/11/2012)
G.B. Morgagni Prizes 2012 Winners
(20/11/2012)
(20/11/2012)
NovAliX and Servier Collaborate in Early Discovery Research Program
(27/10/2012)
Information about Valdoxan for health care professionals
(10/10/2012)
Information about Valdoxan for patients
(10/10/2012)
Servier-Ruijin Talent Development and Scientific Exchanges
(08/10/2012)
Celebrating the 10th Anniversary of Servier Tianjin Pharmaceutical Company
(08/10/2012)
(03/10/2012)
Servier concludes a collaboration and license agreement with EOS for its antitumor drug E-3810
(01/10/2012)
(28/09/2012)
XOMA Announces Servier has Initiated Phase 3 Gevokizumab Trial in Patients with Behçet’s Uveitis
(27/09/2012)
(20/09/2012)
Servier Announces Manufacturing Agreement with Boehringer Ingelheim
(03/08/2012)
(19/07/2012)
(10/07/2012)
IOF-SERVIER Research Grant: the 2012 winner is Mark EDWARDS
(29/06/2012)
(22/06/2012)